US-HEALTH Summary

Sep 13, 2011, 11:14 p.m.

Do teen driving restrictions save lives?

NEW YORK (Reuters Health) - Programs that keep young drivers from taking the wheel at night, or with a car full of teens, may reduce the risk of fatal crashes in some drivers -- but increase that risk in others. A study that compared death rates found fewer fatal crashes among 16-year-olds, but more among 18-year-olds, when states had so-called graduated driver licensing programs in place. And there was no difference in fatal crashes among all teen drivers combined under the programs.

Pfizer to delay infant-nutrition sale: report

(Reuters) - Pfizer Inc is delaying sale of its infant-nutrition business as it is concerned a sale may lead to an increased tax burden, Bloomberg reported, citing people with direct knowledge of the plans. Pfizer may send sales documents to potential buyers in November, two months later than expected, Bloomberg cited the people as saying.

Boston Scientific taps J&J executive as its next CEO

(Reuters) - Boston Scientific Corp named Johnson & Johnson's top medical device executive to be its new president and chief executive, snaring an experienced leader from its larger rival. Michael Mahoney, 46, who is chairman of J&J's medical device and diagnostics business, will become Boston Scientific's president on October 17 and is expected to become CEO next year on Nov 1, 2012. The delay in assuming the CEO post accommodates Mahoney's post-employment obligations with J&J, Boston Scientific said.